FDA again urges lawmakers for new notification authority, funding to address future pandemics
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesCoronavirus/COVID-19Government/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)